Author: Judy Quinn

Study Links New Set of Rare Gene Variants to Autism

The New York Genome Center (NYGC) is proud to be a collaborator in this multi-institutional study led by NYGC Associate Member Evan Eichler, PhD, Professor in the Department of Genome Sciences, University of Washington School of Medicine, identifying new risk genes that may account for up to 4.5% of autism cases. NYGC team member co-authors […]

Dr. Neville Sanjana Interviewed in “What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health” Feature Article

NEW YORK, NY (June 11, 2021) —Neville Sanjana, PhD, Core Faculty Member at the New York Genome Center, Assistant Professor of Biology, New York University, and Assistant Professor of Neuroscience and Physiology, NYU Grossman School of Medicine, is among the scientists weighing in on What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public […]

New Mapping Technique Reveals Epigenetic Drivers of Cancers

NEW YORK, NY (May 10, 2021) – Scientists have made major advances in understanding and developing treatments for many cancers by identifying genetic mutations that drive the disease. Now a team led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and the New York Genome Center (NYGC) has developed a machine learning technique for detecting other […]

Single-Cell CRISPR Technology Deciphers Role of Chromatin Accessibility in Cancer

Mapping the ‘chromatinome’: New integrative functional genomics platform for profiling genome regulation with a massively-parallel screen of chromatin modifiers NEW YORK, NY (April 29, 2021) – In a new resource for the scientific community, published today in Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and […]